Major $115M Fundraising Fuels AI Drug Development

BenevolentAI has raised its second round of fundraising to expand the drug developing capabilities of its artificial intelligence technology. The technology could significantly increase the speed and efficiency of the drug discovery process. BenevelontAI, based in London, has raised $115M (€93M) to ...
à

Kickstarter's focus is on engaging with creative people: Perry Chen

AI ( artificial intelligence ) is one of the biggest changes. We've been dealing with how tech affects us for the past 10-20 years. But ...